DrugPatentWatch Database Preview
Pertuzumab - Biologic Drug Details
Summary for pertuzumab
| Tradenames: | 1 |
| Patents: | 139 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for pertuzumab |
Pharmacology for pertuzumab
| Mechanism of Action | HER2/Neu/cerbB2 Antagonists |
US Patents for pertuzumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | Array BioPharma Inc. (Boulder, CO) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | Pharmacyclics LLC (Sunnyvale, CA) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | University of Georgia Research Foundation, Inc. (Athens, GA) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | MEDIMMUNE, LLC (Gaithersburg, MD) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | Celcuity LLC (Minneapolis, MN) | ➤ Sign Up | RX | search | |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for pertuzumab
| Country | Document Number | Estimated Expiration |
|---|---|---|
| South Korea | 20080063862 | ➤ Sign Up |
| Croatia | P20110171 | ➤ Sign Up |
| Russian Federation | 2014130874 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2004043377 | ➤ Sign Up |
| South Korea | 101622412 | ➤ Sign Up |
| Taiwan | I415610 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for pertuzumab
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 90004-6 | Sweden | ➤ Sign Up | PRODUCT NAME: POMALIDOMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS, SOLVATES, HYDRATES OR STEREOISOMERS THEREOF; REG. NO/DATE: EU/1/13/850 20130808 |
| 2015 00006 | Denmark | ➤ Sign Up | PRODUCT NAME: POMALIDOMID OG FARMACEUTISK ACCEPTABLE SALTE, SOLVATER, HYDRATER ELLER STEREOISOMERER HERAF; REG. NO/DATE: EU/1/13/850 20130805 |
| 2015000013 | Germany | ➤ Sign Up | PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE (IMNOVID); REGISTRATION NO/DATE: EU/1/13/850 20130805 |
| 2 50002-2015 | Slovakia | ➤ Sign Up | PRODUCT NAME: POMALIDOMID; REGISTRATION NO/DATE: EU/1/13/850/001 - EU/1/13/850/004 20130808 |
| 00717 | Netherlands | ➤ Sign Up | PRODUCT NAME: POMALIDOMIDE EN FARMACEUTISCH AANVAARDBARE ZOUTEN, SOLVATEN, HYDRATEN OF STEREOISOMEREN DAARVAN; REGISTRATION NO/DATE: EU/1/13/850 20130805 |
| 0717 | Netherlands | ➤ Sign Up | PRODUCT NAME: POMALIDOMIDE EN FARMACEUTISCH AANVAARDBARE ZOUTEN, SOLVATEN, HYDRATEN OF STEREOISOMEREN DAARVAN; REGISTRATION NO/DATE: EU/1/13/850 20130805 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
